| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |